Group One Trading’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $20.9M | Buy |
868,402
+276,169
| +47% | +$7.22M | 0.03% | 523 |
|
|
2026
Q1 | $16.6M | Buy |
592,233
+432,806
| +271% | +$11.5M | 0.03% | 579 |
|
|
2025
Q4 | $3.97M | Sell |
159,427
-60,319
| -27% | -$1.52M | 0.01% | 1704 |
|
|
2025
Q3 | $5.6M | Sell |
219,746
-78,620
| -26% | -$1.94M | 0.01% | 1385 |
|
|
2025
Q2 | $7.23M | Sell |
298,366
-91,562
| -23% | -$2.14M | 0.02% | 1041 |
|
|
2025
Q1 | $9.88M | Buy |
+389,928
| New | +$10.2M | 0.03% | 629 |
|
|
2024
Q4 | – | Sell |
-330,485
| Closed | -$8.96M | – | 7801 |
|
|
2024
Q3 | $9.56M | Buy |
330,485
+157,360
| +91% | +$4.59M | 0.03% | 645 |
|
|
2024
Q2 | $4.84M | Sell |
173,125
-445,008
| -72% | -$12.3M | 0.02% | 820 |
|
|
2024
Q1 | $17.2M | Sell |
618,133
-132,337
| -18% | -$3.67M | 0.07% | 231 |
|
|
2023
Q4 | $21.6M | Buy |
750,470
+303,559
| +68% | +$9.18M | 0.06% | 317 |
|
|
2023
Q3 | $14.8M | Buy |
446,911
+304,500
| +214% | +$10.8M | 0.05% | 333 |
|
|
2023
Q2 | $5.22M | Buy |
142,411
+85,609
| +151% | +$3.33M | 0.02% | 927 |
|
|
2023
Q1 | $2.32M | Sell |
56,802
-351,459
| -86% | -$15.2M | 0.01% | 1409 |
|
|
2022
Q4 | $20.9M | Buy |
408,261
+147,625
| +57% | +$7.08M | 0.05% | 390 |
|
|
2022
Q3 | $11.4M | Sell |
260,636
-131,734
| -34% | -$6.4M | 0.02% | 655 |
|
|
2022
Q2 | $20.6M | Buy |
+392,370
| New | +$20M | 0.03% | 470 |
|
|
2021
Q4 | – | Sell |
-396,879
| Closed | -$19.7M | – | 8697 |
|
|
2021
Q3 | $17.1M | Sell |
396,879
-443,548
| -53% | -$19.6M | 0.02% | 709 |
|
|
2021
Q2 | $32.9M | Buy |
840,427
+599,681
| +249% | +$23.3M | 0.04% | 385 |
|
|
2021
Q1 | $8.72M | Sell |
240,746
-278,940
| -54% | -$9.9M | 0.01% | 1040 |
|
|
2020
Q4 | $19.1M | Buy |
519,686
+428,802
| +472% | +$15.7M | 0.03% | 468 |
|
|
2020
Q3 | $3.17M | Sell |
90,884
-113,027
| -55% | -$3.96M | 0.01% | 1231 |
|
|
2020
Q2 | $6.33M | Sell |
203,911
-88,114
| -30% | -$2.99M | 0.03% | 665 |
|
|
2020
Q1 | $9.04M | Buy |
292,025
+92,714
| +47% | +$3.16M | 0.07% | 298 |
|
|
2019
Q4 | $7.41M | Buy |
199,311
+34,035
| +21% | +$1.21M | 0.05% | 482 |
|
|
2019
Q3 | $5.63M | Buy |
+165,276
| New | +$6.01M | 0.05% | 517 |
|
|
2017
Q4 | – | Sell |
-108,698
| Closed | -$3.71M | – | 5127 |
|
|
2017
Q3 | $3.68M | Sell |
108,698
-5,908
| -5% | -$190K | 0.03% | 658 |
|
|
2017
Q2 | $3.65M | Sell |
114,606
-61,961
| -35% | -$1.95M | 0.04% | 617 |
|
|
2017
Q1 | $5.73M | Sell |
176,567
-332,207
| -65% | -$10.5M | 0.07% | 355 |
|
|
2016
Q4 | $15.7M | Buy |
508,774
+194,840
| +62% | +$5.95M | 0.15% | 134 |
|
|
2016
Q3 | $10.1M | Buy |
+313,934
| New | +$10.5M | 0.11% | 184 |
|
|
2016
Q2 | – | Sell |
-357,231
| Closed | -$11.4M | – | 4867 |
|
|
2016
Q1 | $10M | Buy |
+357,231
| New | +$10.2M | 0.14% | 137 |
|
|
2015
Q2 | – | Sell |
-30,577
| Closed | -$997K | – | 5090 |
|
|
2015
Q1 | $1.01M | Buy |
30,577
+30,472
| +29,021% | +$969K | 0.02% | 1077 |
|
|
2014
Q4 | $3K | Buy |
+105
| New | +$3.01K | ﹤0.01% | 4618 |
|
Other funds holding PFE
Group One Trading's PFE Position: Q2 2026 in Review
Group One Trading increased its Pfizer (PFE) stake by 47% in Q2 2026, buying an estimated $7.22M and bringing the position to 868,402 shares worth $20.9M. The position accounts for 0.03% of the portfolio, ranked #523.
Group One Trading first reported a position in PFE in Q4 2014 and has held it in 33 quarters since. The position peaked at $32.9M in Q2 2021. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Group One Trading held 868,402 shares of Pfizer worth $20.9M as of Q2 2026.
- Group One Trading bought 276,169 Pfizer shares in Q2 2026, an estimated $7.22M.
- Pfizer made up 0.03% of Group One Trading's portfolio in Q2 2026, its #523 holding.
- Group One Trading first reported a position in Pfizer in Q4 2014 and has held it in 33 quarters since.
- Group One Trading's Pfizer position peaked at $32.9M in Q2 2021.
- 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.